Revisiting the role of inflammation in the loss of pancreatic β-cells in T1DM

Islet inflammation (insulitis) in type 1 diabetes mellitus is triggered by a deleterious dialogue between β-cells and the immune system, inducing β-cell dysfunction and death. This concept, outlined in our 2009 Review, has been confirmed and extended. Here, we provide a brief update of the field and outline key pending questions.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: An updated view of the dialogue between β-cells and the immune system.


  1. 1.

    Eizirik, D. L., Colli, M. L. & Ortis, F. The role of inflammation in insulitis and β-cell loss in type 1 diabetes. Nat. Rev. Endocrinol. 5, 219–226 (2009).

    CAS  Article  Google Scholar 

  2. 2.

    Oram, R. A., Sims, E. K. & Evans-Molina, C. Beta cells in type 1 diabetes: mass and function; sleeping or dead? Diabetologia 62, 567–577 (2019).

    CAS  Article  Google Scholar 

  3. 3.

    Eizirik, D. L., Pasquali, L. & Cnop, M. Pancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure. Nat. Rev. Endocrinol. 16, 349–362 (2020).

    CAS  Article  Google Scholar 

  4. 4.

    Ramos-Rodríguez, M. et al. The impact of proinflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes. Nat. Genet. 51, 1588–1595 (2019).

    CAS  Article  Google Scholar 

  5. 5.

    James, E. A., Mallone, R., Kent, S. C. & DiLorenzo, T. P. T-cell epitopes and neo-epitopes in type 1 diabetes: a comprehensive update and reappraisal. Diabetes 69, 1311–1335 (2020).

    Article  Google Scholar 

  6. 6.

    Op de Beeck, A. & Eizirik, D. L. Viral infections in type 1 diabetes mellitus — why the β cells? Nat. Rev. Endocrinol. 12, 263–273 (2016).

    CAS  Article  Google Scholar 

  7. 7.

    Marroqui, L. et al. Interferon-α mediates human beta cell HLA class I overexpression, endoplasmic reticulum stress and apoptosis, three hallmarks of early human type 1 diabetes. Diabetologia 60, 656–667 (2017).

    CAS  Article  Google Scholar 

  8. 8.

    Coomans de Brachène, A. et al. Preclinical evaluation of tyrosine kinase 2 inhibitors for human beta-cell protection in type 1 diabetes. Diabetes Obes. Metab. (2020).

    Article  PubMed  Google Scholar 

  9. 9.

    Colli, M. L. et al. An integrated multi-omics approach identifies the landscape of interferon-α-mediated responses of human pancreatic beta cells. Nat. Commun. 11, 2584 (2020).

    CAS  Article  Google Scholar 

  10. 10.

    Hostens, K. et al. Exposure of human islets to cytokines can result in disproportionately elevated proinsulin release. J. Clin. Invest. 104, 67–72 (1999).

    CAS  Article  Google Scholar 

Download references


The authors acknowledge the support of grants from the JDRF (2-SRA-2019-834-S-B); Welbio and Fonds National de la Recherche Scientifique (FNRS), Belgium, grants CR-2015A-06 and CR-2019C-04; Innovate2CureType1-Dutch Diabetes Research Fundation (DDRF); and start-up funding provided by the Indiana Biosciences Research Institute. D.L.E. has also received funding from the Innovative Medicines Initiative Joint Undertaking under grant agreements nos 115797 and 945268 (INNODIA and INNODIA HARVEST). This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and “EFPIA”, “JDRF” and “The Leona M. and Harry B. Helmsley Charitable Trust”.

Author information



Corresponding authors

Correspondence to Decio L. Eizirik or Maikel L. Colli.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Eizirik, D.L., Colli, M.L. Revisiting the role of inflammation in the loss of pancreatic β-cells in T1DM. Nat Rev Endocrinol 16, 611–612 (2020).

Download citation

Further reading


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing